Page last updated: 2024-08-17

medroxyprogesterone acetate and Atheroembolism

medroxyprogesterone acetate has been researched along with Atheroembolism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hsia, J; Jacobs, H; Katz, RJ; Kessler, C; Walker, P	1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Atheroembolism

Article	Year
Effects of hormone replacement therapy on the circadian pattern of atherothrombotic risk factors. The American journal of cardiology, 1996, Oct-15, Volume: 78, Issue:8 Topics: Circadian Rhythm; Embolism, Cholesterol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator; Triglycerides	1996

Article

Year

Effects of hormone replacement therapy on the circadian pattern of atherothrombotic risk factors.

The American journal of cardiology, 1996, Oct-15, Volume: 78, Issue:8

Topics: Circadian Rhythm; Embolism, Cholesterol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator; Triglycerides

1996